Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study - Agnelli, G; Gallus, A; Goldhaber, S ZODIXa-DVT Study Investigators (Circulation, 2007)
, et al;